CD4++ CD28++ lymphocytes on day 5 after high-dose melphalan for multiple myeloma predict a low risk of infections during severe neutropenia and are associated with the number of reinfused T lymphocytes of the autologous stem cell graft

Author： Schmidmaier Ralf   Then Cornelia   Schnabel Brigitte   Oduncu Fuat   Baumann Philipp   Straka Christian  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.13, Iss.8, 2011-09, pp. : 987-992

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Correlation of residual leukocyte subsets with neutropenic fever during severe leukopenia after high-dose chemotherapy and autologous stem cell transplantation

By Schnabel B   Schmidmaier R   Franke D   Emmerich B   Straka C  

Cytotherapy, Vol. 8, Iss. 5, 2006-11 ,pp. : 473-479

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Impaired PBPC collection in patients with myeloma after high-dose melphalan

By Jansen J   Thompson JM   Dugan MJ   Wiemann MC   Hanks S   Greenspan AR   Akard LP  

Cytotherapy, Vol. 6, Iss. 5, 2004-10 ,pp. : 498-504

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Regulatory T-cell depletion does not prevent emergence of new CD25+ FOXP3+ lymphocytes after antigen stimulation in culture

By Melenhorst Jj   Scheinberg P.   Lu J.   Sosa E.   Zhao L.   Hensel Nf   Savani Bn   Douek Dc   Price Da.   Barrett Aj  

Cytotherapy, Vol. 10, Iss. 2, 2008-02 ,pp. : 152-164

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Selection of autologous CD4+ T-cells for adoptive T-cell substitution in patients with CD23+ B-cell CLL

By Dettke M   Berger R   Jurko S   Mitterbauer G   Schwarzmeier JD   Höcker P  

Cytotherapy, Vol. 4, Iss. 2, 2002-03 ,pp. : 119-125

Ashgate Publishing Ltd

Access to resources Recommend Favorite

High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer

By Braunschweig I.   Mirza N.Q.   Rondon G.   Lauppe J.   Mehra R.   Gajewski J.   Körbling M.   Huh Y.O.   Geisler D.   Gee A.P.   Champlin R.   Przepiorka D.  

Cytotherapy, Vol. 2, Iss. 2, 2000-02 ,pp. : 105-110

Ashgate Publishing Ltd

Access to resources Recommend Favorite